WHO encourages countries to adapt HIV testing strategies in response to changing epidemic
27 November 2019
| Policy brief
Overview
HIV testing services (HTS) and anti-retroviral therapy (ART) have been scaled up substantially. It is estimated that, globally, nearly 80% of people with HIV now know their status. With the offer of immediate ART initiation and improved treatment options, access to and uptake of treatment have increased, too. Now, most people with HIV who know their status are obtaining treatment and care.
In response to these changes in the global HIV epidemic, WHO is encouraging countries to use three consecutive reactive tests for an HIV-positive diagnosis as their treatment-adjusted prevalence and national HTS positivity fall below 5% .
Related policy briefs
- Consolidated guidelines on HIV testing services for a changing epidemic
- WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms
- WHO recommends social network-based HIV testing approaches for key populations as part of partner services package
- Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care
- WHO recommends HIV self-testing – evidence update and considerations for success
- What works for generating demand for HIV testing services
WHO Team
HIV/AIDS
Number of pages
4
Reference numbers
WHO Reference Number: WHO/CDS/HIV/19.34
Copyright
WHO